Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Dore

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Current Medical Research and Opinion|October 18, 2025
Patient and physician preferences among colorectal cancer screening tests: updated predictions from a discrete choice experimentA Mark Fendrick, Mallik Greene, A Burak Ozbay, et al.
American Journal of Preventive Medicine|May 16, 2025
Multi-target stool DNA and the Fecal Immunochemical Test: A Systematic Review and Meta-analysis on Test PerformancesDerek W Ebner, Heather A Johnson, Chris Estes, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 2009
Identification of a PPARdelta agonist with partial agonistic activity on PPARgammaRichard V Connors, Zhulun Wang, Martin Harrison, et al.
Journal of Medicinal Chemistry|January 29, 2019
Optimization of Fused Bicyclic Allosteric SHP2 InhibitorsJeffrey T Bagdanoff, Zhouliang Chen, Michael Acker, et al.
Journal of Medicinal Chemistry|March 23, 2019
Correction to Optimization of Fused Bicyclic Allosteric SHP2 InhibitorsJeffrey T Bagdanoff, Zhouliang Chen, Michael Acker, et al.
Journal of Medicinal Chemistry|September 10, 2020
Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of CancerMatthew J LaMarche, Michael Acker, Andreea Argintaru, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Current Medical Research and Opinion|October 18, 2025
Patient and physician preferences among colorectal cancer screening tests: updated predictions from a discrete choice experimentA Mark Fendrick, Mallik Greene, A Burak Ozbay, et al.
American Journal of Preventive Medicine|May 16, 2025
Multi-target stool DNA and the Fecal Immunochemical Test: A Systematic Review and Meta-analysis on Test PerformancesDerek W Ebner, Heather A Johnson, Chris Estes, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 2009
Identification of a PPARdelta agonist with partial agonistic activity on PPARgammaRichard V Connors, Zhulun Wang, Martin Harrison, et al.
Journal of Medicinal Chemistry|January 29, 2019
Optimization of Fused Bicyclic Allosteric SHP2 InhibitorsJeffrey T Bagdanoff, Zhouliang Chen, Michael Acker, et al.
Journal of Medicinal Chemistry|March 23, 2019
Correction to Optimization of Fused Bicyclic Allosteric SHP2 InhibitorsJeffrey T Bagdanoff, Zhouliang Chen, Michael Acker, et al.
Journal of Medicinal Chemistry|September 10, 2020
Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of CancerMatthew J LaMarche, Michael Acker, Andreea Argintaru, et al.
Pageof 4